MICHELLE HOFKES: Open Payments
NPI 1366143968 · BELOIT, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,691 in 86 payments from 33 companies in 2025. Trend: 2023 $718 · 2024 $437 · 2025 $1,691
Food & beverage: $1,691
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $306 |
| Janssen Biotech, Inc. | 9 | $206 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| ABBVIE INC. | 4 | $99 |
| Astellas Pharma US Inc | 4 | $89 |
| Pharmacosmos Therapeutics Inc. | 3 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Genentech USA, Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
Products named: TECVAYLI, EPKINLY, KISQALI, Fabhalta, MONOFERRIC, SCEMBLIX, IMFINZI, Nubeqa.
Industry payments across WI — which companies pay providers there.
